Colossal Biosciences Secures $200 Million to Advance De-Extinction Efforts
16.01.2025, 18:00
Colossal Biosciences, a Texas-based startup, has raised $200 million in its Series C funding round, propelling the company to a valuation of over $10 billion. The funds will support its ambitious project to revive extinct species, including the woolly mammoth, thylacine, and dodo. Recent scientific...